person · Reporting owner
Denti Aldo Mariano Roberto
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | EVP, Chief Commercial Officer | March 11, 2026 | March 12, 2026 |
| Imricor Medical Systems, Inc.IMR · Entity 45877 | Director | May 18, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date March 11, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock (Supplemental Executive Retirement Plan) SERPSEC Table II · derivative / convertible security | Direct | 829.396 |
Reported balance
After 2026-03-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-11 · Grant · Acquired 829.396 · Balance 829.396 F1: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. F2: Comprised of phantom stock. F3: Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
F2: Comprised of phantom stock.
F3: Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.
Imricor Medical Systems, Inc.
Report date May 18, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 23,007 |
Reported balance
Holding disclosure · report date 2026-05-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 23,007 F1: The amount of securities beneficially owned in column 2 consists entirely of restricted stock awards ("RSAs") granted under the issuer's 2019 Equity Incentive Plan. Each RSA represents one share of the issuer's Class A Common Stock subject to vesting conditions. The reporting person holds 23,007 RSAs granted on May 8, 2026, subject to 4-year vesting; the RSAs will vest 25% on each of May 8, 2027, May 8, 2028, May 8, 2029, and May 8, 2030, subject to the reporting person's continued service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount of securities beneficially owned in column 2 consists entirely of restricted stock awards ("RSAs") granted under the issuer's 2019 Equity Incentive Plan. Each RSA represents one share of the issuer's Class A Common Stock subject to vesting conditions. The reporting person holds 23,007 RSAs granted on May 8, 2026, subject to 4-year vesting; the RSAs will vest 25% on each of May 8, 2027, May 8, 2028, May 8, 2029, and May 8, 2030, subject to the reporting person's continued service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2026 Filed Mar 12, 2026 21:41 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 829.396 | $11.43 | $9,480.00 |
DisclosureSEC source: 0000818479-26-000113 · form4.xml · derivative · entry 1 Denti Aldo Mariano Roberto · CIK 0002091477 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 829.396 Underlying: Common Stock · 829.396 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. F2 · shares: Comprised of phantom stock. F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 270,200 | $0.00 Strike: $14.78 | $0.00 |
DisclosureSEC source: 0000818479-26-000102 · form4.xml · derivative · entry 2 Denti Aldo Mariano Roberto · CIK 0002091477 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,200 Underlying: Common Stock · 270,200 shares Expires 2036-03-04 F2 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 59,524 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000102 · form4.xml · nonDerivative · entry 1 Denti Aldo Mariano Roberto · CIK 0002091477 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,524 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.